Table 1 Demographic and clinical profiles of the study population
Variable | N (%) |
|---|---|
Age (N = 9,079) | |
<5 years | 2,477 (27.28) |
5–15 years | 2,811 (30.96) |
>15 years | 3,791 (41.76) |
Gender (N = 9,094) | |
Female | 5,417 (59.57) |
Male | 3,677 (40.43) |
Anaemia (N = 8,991) | |
No anaemia (>12.9 g/dl) | 2,198 (24.45) |
Mild (11.0–12.9 g/dl) | 3,783 (42.08) |
Moderate (8.0–10.9 g/dl) | 2,671 (29.70) |
Severe (<8.0 g/dl) | 339 (3.77) |
Has received indoor residual spraying in past 1 year (N = 9,094) | |
Yes | 7,170 (78.84) |
No | 1,924 (21.16) |
Has slept under a LLIN the previous night (N = 8,621) | |
Yes | 8,244 (95.63) |
No | 377 (4.37) |
Has slept outdoors at night (N = 9,064) | |
Yes | 3,807 (42.0) |
No | 5,257 (58.0) |
Has used an LLIN outdoors at night (N = 3,689) | |
Yes | 1,405 (38.09) |
No | 2,284 (61.91) |
Has history of fever in the last 24 h (N = 9,094) | |
Yes | 4,195 (46.13) |
No | 4,899 (53.87) |
Presence of fever (axillary temperature ≥37.5 °C) (N = 9,094) | |
Yes | 498 (5.48) |
No | 8,596 (94.52) |
Has taken artemether-lumefantrine in past 2 weeks (N = 9,094) | |
Yes | 174 (1.91) |
No | 8,920 (98.09) |